Recombination Expression and Cytolytic Bioactivity of vvhA Fusion Protein:Cytolysin of V.vulnificus

Jing Gui,Mei-Ying Xiao,Yong-Liang Lou,Die Hu,Jie Yan,Ye-Jing Zhu
DOI: https://doi.org/10.3969/j.issn.1674-7666.2008.01.018
2008-01-01
Abstract:The aim of the study is to investigate cytolytic bioactivity of vvhA fusion protein (rVvhA): cytolysin of V.vulnificus on the apoptosis of human ECV304 cells. rVvhA was expressed highly in E.coli BL21 (DE3) bearing recombinant plasmid pET-28a(+)vvhA induced by 0.5 mmol/L IPTG. The expressed product was denatured and then purified by metal affinity chromatography using Ni2+-NTA resin. Finally, rVvhA was refolded using dilution and step dialysis. The bioactivity of rVvhA was confirmed by cytolysis against sheep erythrocytes and evaluated by MTT, Hoechst33342/PI fluorescent staining and flow cytometry. The results showed that rVvhA was purified to a purity of 88.6%. The fusion protein had a cytotoxic effect against sheep erythrocytes in time- and dose- dependent manner and reduced the viability of human ECV304 cells in a dose-dependent manner; The caspase pan inhibitor, Z-VAD-FMK, can partially inhibit rVvhA induced apoptosis. rVvhA has cytotoxic effect on human ECV304 cells and this process is probably correlated with the activation of caspase.
What problem does this paper attempt to address?